Diagnoses of gender dysphoria in English minors attending primary care practices increased by 50-fold from 2011 to 2021, according to a new study.
I tucked this finding into the report I published Thursday in The New York Sun about a new pair of systematic literature review and meta-analysis papers that found that prescribing puberty blockers and cross-sex hormones to treat gender dysphoria in young people is based on “very low certainty evidence.”
I wanted to go into greater detail about the dysphoria-diagnosis study in this Substack.
